Moreover, our experimental results show that morphometric markers from the hippocampal subiculum and CA1 subfield are apparently associated with Aβ/tau markers in all the clinically defined stages of AD and, as AD pathology progress, the ROIs showing associations are more focal. The gene discussed is MAPT; the disease is Alzheimer disease.